0
Simulations Plus, Inc. Banner Image

Simulations Plus, Inc. has reached its limit for free report views

Work for Simulations Plus, Inc.? Upgrade Your Profile and unlock all your annual reports.

Simulations Plus, Inc.

  • Ticker SLP
    Exchange NASDAQ More
  • Industry Healthcare Information Services More
  • Sector Healthcare More
Simulations Plus, Inc. Logo Image
  • 51-200 Employees
  • Based in Lancaster, California
Simulations Plus, Inc. (NASDAQ: SLP) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research and regulatory submissions. They partner with companies to provide a data-driven, ‘strategic modeling methodology’, starting in early discovery, continuing through preclinical/clinical development, and concluding with clinicalMore trials/post approval. With their subsidiaries, Cognigen Corporation and DILIsym Services, they offer #1-ranked, easy-to-use software (GastroPlus®, ADMET Predictor®, KIWI™, DILIsym®, NAFLDsym®, PKPlus™, and more) to bridge data mining, compound library screening with QSAR models, PBPK/TK modeling & simulation in animals and humans following administration around the body, and quantitative systems pharmacology approaches. Simulations Plus technology is licensed to and used by regulatory agencies worldwide.
Simulations Plus, Inc.

Most Recent Annual Report

Simulations Plus, Inc. MOST RECENT 2020 Annual Report

Report Locked. Simulations Plus, Inc. has reached its limit for free report views.

Older/Archived Annual Reports